Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Luliconazole

Luliconazole

pharmaceutical raw materials
Luliconazole structure

Luliconazole 

structure
  • CAS No:

    187164-19-8

  • Formula:

    C14H9Cl2N3S2

  • Chemical Name:

    Luliconazole

  • Synonyms:

    1H-Imidazole-1-acetonitrile,α-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-,(αE)-;1H-Imidazole-1-acetonitrile,α-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-,[R-(E)]-;(αE)-α-[(4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene]-1H-imidazole-1-acetonitrile;NND 502;Luliconazole;Lulicon;Luzu

  • Categories:

    Active Pharmaceutical Ingredients  >  Synthetic Anti-infective Drugs

Description

Luliconazole is a member of the imidazole class of antifungal agents, with specific utility as a dermatological antimycotic drug. It was launched in Japan as a topical agent for the treatment of athlete’s foot. Luliconazole is an optically active drug with (R)-configuration at its chiral center. It is structurally related to lanoconazole, which has been marketed as a racemic mixture since 1994. As with other azole antifungal drugs, the mechanism of action of luliconazole is the inhibition


Luliconazole is a dichlorobenzene.|Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan.|Luliconazole is an Azole Antifungal. The mechanism of action of luliconazole is as a Cytochrome P450 2C19 Inhibitor.

Luliconazole Basic Attributes

354.28

354.28

RE91AN4S8G

DTXSID3048607

D - Dermatologicals

Characteristics

92.2

4

1.52±0.1 g/cm3(Predicted)

499.1±55.0 °C(Predicted)

255.6±31.5 °C

1.734

4.27E-10mmHg at 25°C

Safety Information

P305 + P351 + P338

H315; H319

Toxicity

In clinical trials, no serious toxicity was reported, only local irritation (mild contact dermatitis and cellulitis) at the site of application was found.

Plasma protein binding of luliconazole is >99%.

Drug Information

Luliconazole is indicated in adults aged 18 years and older for the topical treatment of fungal infections caused by Trichophyton rubrum and Epidermophyton floccosum, specifically tinea pedis, cruris, and corporis.|FDA Label

Luliconazole kills the organisms Trichophyton rubrum and Epidermophyton floccosum, most likely by altering their fungal cell membranes.

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)

Although luliconazole is administered topically, clinical studies have shown that after the first dose in patients with tina pedis, a maximum plasma concentration of 0.40 ± 0.76 ng/mL (mean ± SD) occurred in 16.9 ± 9.39 hours (mean ± SD).|The route of elimination of luliconazole has yet to be determined.|The volume of distribution was not quantified.|The clearance of luliconazole has yet to be determined.

The metabolism of luliconazole has yet to be determined.

The half life of luliconazole has yet to be determined.

The exact mechanism of action for luliconazole's anti-fungal activity is still not known, but luliconazole is thought to inhibit the enzyme lanosterol demethylase. Lanosterol demethylase is needed for the synthesis of ergosterol, which is a major component of the fungus cell membranes.

(2E)-((4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)(1H-imidazol-1-yl)acetonitrile

Luliconazole Use and Manufacturing

Uses

It can be used for the following fungal infections:
Ringworm: athlete's foot, ringworm, jock itch;
Candida infections: disease fingers erosion, intertrigo; vitiligo.

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:354.3
XLogP3:4
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:2
Exact Mass:352.9614950
Monoisotopic Mass:352.9614950
Topological Polar Surface Area:92.2
Heavy Atom Count:21
Complexity:476
Defined Atom Stereocenter Count:1
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Extract from the above information

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • MAITHRI DRUGS PRIVATE LTD

    United States United States
    Active
  • HAMARI PFST LTD

    United States United States
    Active
  • ALIVUS LIFE SCIENCES LTD

    United States United States
    Active

Recommended Suppliers of Luliconazole

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.